SE452550B - Tablett med fordrojd frigoring av teofyllin - Google Patents

Tablett med fordrojd frigoring av teofyllin

Info

Publication number
SE452550B
SE452550B SE8102814A SE8102814A SE452550B SE 452550 B SE452550 B SE 452550B SE 8102814 A SE8102814 A SE 8102814A SE 8102814 A SE8102814 A SE 8102814A SE 452550 B SE452550 B SE 452550B
Authority
SE
Sweden
Prior art keywords
tablet
theophylline
tablet according
weight
hours
Prior art date
Application number
SE8102814A
Other languages
English (en)
Swedish (sv)
Other versions
SE8102814L (sv
Inventor
S T David
D Brooke
C E Gallian
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8102814L publication Critical patent/SE8102814L/
Publication of SE452550B publication Critical patent/SE452550B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8102814A 1980-05-06 1981-05-05 Tablett med fordrojd frigoring av teofyllin SE452550B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (2)

Publication Number Publication Date
SE8102814L SE8102814L (sv) 1981-11-07
SE452550B true SE452550B (sv) 1987-12-07

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102814A SE452550B (sv) 1980-05-06 1981-05-05 Tablett med fordrojd frigoring av teofyllin

Country Status (17)

Country Link
AT (1) AT380789B (de)
AU (1) AU549299B2 (de)
CA (1) CA1165241A (de)
CY (1) CY1368A (de)
DE (1) DE3117756A1 (de)
DK (1) DK155976C (de)
FI (1) FI811356L (de)
FR (1) FR2484253A1 (de)
GB (1) GB2078518B (de)
HK (1) HK4288A (de)
IE (1) IE51157B1 (de)
IT (1) IT1209867B (de)
KE (1) KE3722A (de)
LU (1) LU83342A1 (de)
NL (1) NL8102168A (de)
SE (1) SE452550B (de)
SG (1) SG30987G (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (de) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
CA1165241A (en) 1984-04-10
KE3722A (en) 1987-04-30
FI811356L (fi) 1981-11-07
ATA202081A (de) 1985-12-15
HK4288A (en) 1988-01-29
IE51157B1 (en) 1986-10-15
IT8148406A0 (it) 1981-05-06
DE3117756A1 (de) 1982-04-29
AU549299B2 (en) 1986-01-23
DK200181A (da) 1981-11-07
AT380789B (de) 1986-07-10
DK155976C (da) 1989-10-30
LU83342A1 (fr) 1982-01-20
FR2484253B1 (de) 1983-06-03
FR2484253A1 (fr) 1981-12-18
GB2078518A (en) 1982-01-13
NL8102168A (nl) 1981-12-01
GB2078518B (en) 1984-04-11
CY1368A (en) 1987-08-07
SG30987G (en) 1987-07-17
IT1209867B (it) 1989-08-30
DK155976B (da) 1989-06-12
IE810989L (en) 1981-11-06
DE3117756C2 (de) 1992-11-26
AU7020581A (en) 1981-11-12

Similar Documents

Publication Publication Date Title
RU2140266C1 (ru) Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения
US4465660A (en) Sustained release tablet containing at least 95 percent theophylline
JP2509226B2 (ja) ニトロフラントイン投薬型
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
JP6174666B2 (ja) ナルトレキソンの徐放型配合物
JP2008518914A (ja) アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物
Woodford et al. Relative bioavailability of aspirin gum
CA1140466A (en) Pharmaceutical compositions
EP0025686B1 (de) Paracetamol enthaltende pharmazeutische Zusammensetzung, die Zusammensetzung enthaltende Behandlungspackung und Verfahren zum Reduzieren des toxischen Effektes von Paracetamol-Zusammensetzungen in der Leber
SE452550B (sv) Tablett med fordrojd frigoring av teofyllin
CN101524355A (zh) 抗结核药物的复方制剂及其制备方法
JPH11158066A (ja) イブプロフェン含有医薬製剤
Patil et al. Development and evaluation of time controlled pulsatile release Lisinopril tablets
GB2164556A (en) Sustained release pharmaceutical tablet of theophylline and production process therefor
ORGAIN et al. Clofibrate and androsterone effect on serum lipids
Sahoo et al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF GRANISETRON HYDROCHLORIDE USING PLANTAGO OVATE AS NATURAL SUPERDISINTEGRANTS.
JP3653747B2 (ja) コデイン含有カプセル剤
RU2207116C1 (ru) Лекарственное средство в виде таблеток на основе экстракта пустырника
RU2183116C1 (ru) Фармацевтическая композиция, обладающая болеутоляющим, противовоспалительным, антипиретическим и спазмолитическим действием
Shakur et al. Design, Development and Characterization of Giliclazide Delayed Release Tablet for better Therapeutic Efficacy
CN105920017B (zh) 一种治疗单纯性肥胖症的药物组合物及其用途
Phillips et al. Physical form as a determinant of effect of buffered acetylsalicylate formulations on GI microbleeding
JPH0136444B2 (de)
RU2257208C1 (ru) Фармацевтическая композиция, обладающая гепатозащитным действием, и лекарственное средство
Thorat et al. FORMULATION AND EVALUATION OF MANDUR BHASMA TABLET IN THE TREATMENT OF IRON DEFICIENCY ANEMIA

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8102814-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8102814-4

Format of ref document f/p: F